Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other neoplasm 1Dermatologic 1

Conditions

Arthritis, Rheumatoid 5Inflammatory Bowel Diseases 2Colitis, Ulcerative 2Spondylitis, Ankylosing 1Psoriasis 1Precancerous Conditions 1Melanoma 1Infections 1Hepatitis C 1Crohn Disease 1Arthritis 1

Interventions

Polymerase Chain Reaction 4Immunohistochemistry 4Biopsy 4Microarray Analysis 3Gene Expression Profiling 3Mass Spectrometry 2In Situ Hybridization, Fluorescence 2Cytogenetic Analysis 2Comparative Genomic Hybridization 2Blood Specimen Collection 2tremelimumab 1Vaginal Smears 1Tomography, Optical Coherence 1Tamoxifen 1Ribavirin 1Radioimmunodetection 1Papanicolaou Test 1Molecular Diagnostic Techniques 1Methylation 1Infliximab 1Immunoenzyme Techniques 1Histological Techniques 1Genetic Linkage 1Flow Cytometry 1Fentanyl 1Early Intervention, Educational 1Diagnosis, Computer-Assisted 1Colposcopy 1Chromatography, Liquid 1Chromatography, High Pressure Liquid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Precancerous Conditions × Infliximab × Clear all
NCT00897312 2016-04-25

Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease

Vanderbilt-Ingram Cancer Center

Terminated
7 enrolled
DermatologicOther neoplasm

Hepatitis C, Melanoma, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡